The safety of topical beta-blockers in glaucoma treatment.
While adverse effects are uncommon in patients who are otherwise fit and well, doctors should be aware of the implications of the systemic effects of these drugs, particularly the non-selective types, and particularly in the elderly.
Goldberg
I
I
Department of Ophthalmology, Prince of Wales Hospital.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D000367:Age Factors; D000368:Aged; D015784:Betaxolol / Q000008:administration & dosage / Q000009:adverse effects; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D002040:Levobunolol / Q000008:administration & dosage / Q000009:adverse effects; D009883:Ophthalmic Solutions; D012449:Safety; D013999:Timolol / Q000008:administration & dosage / Q000009:adverse effects
D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D013999:Timolol; D002040:Levobunolol; D015784:Betaxolol